Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 30.11.2023

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
30.11.23SolarBank Corporation: SolarBank Announces First Quarter Results4Revenue for the three month period of $7.7 million Net income for the three month period of $2 million or $0.08 per share (undiluted) Reaffirmed revenue guidance of $45 million to $50 million for...
► Artikel lesen
30.11.23Xbrane Biopharma AB: Xbrane Biopharma releases Interim report for January - September 202345Xbrane Biopharma AB's (publ.) ("Xbrane") interim report for January - September 2023, is as of today, available on the Company's website, www.xbrane.com. FINANCIAL OVERVIEWTHIRD QUARTER 2023*• Revenue...
► Artikel lesen
30.11.23Tornos Holding AG: Tornos-Aktionärinnen und -Aktionäre stimmen Fusion mit Starrag zu; Dekotierung der Tornos Holding AG von SIX Swiss Exchange per 8. Dezember 2023453Die ausserordentliche Tornos-Generalversammlung vom 30. November 2023 hat die Fusion der Tornos Holding AG mit der Starrag Group Holding AG und den Fusionsvertrag gutgeheissen. Wie angekündigt, werden...
► Artikel lesen
30.11.23Banc of California Announces Completion of Transformational Merger with PacWest Bancorp and $400 Million Equity Raise493LOS ANGELES--(BUSINESS WIRE)--Banc of California, Inc. ("Banc of California") (NYSE: BANC) today announced the completion of its transformational merger with PacWest Bancorp ("PacWest") (Nasdaq: PACW)...
► Artikel lesen
30.11.23Mallinckrodt plc - 8-K, Current Report2
30.11.23GlucoTrack, Inc.: Glucotrack Announces 180-day Extension To Regain Compliance With Nasdaq Minimum Bid Price Requirement257Rutherford, NJ, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical device company focused on glucose monitoring technologies for people with...
► Artikel lesen
30.11.23Beyond, Inc.: Beyond Board of Directors Unanimously Votes to Enhance Governance and Accountability through Declassification349MIDVALE, Utah, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Beyond, Inc., (NYSE: BYON) ("Beyond" or the "Company"), the parent company of online furniture and home furnishings retailer Bed Bath & Beyond, formerly...
► Artikel lesen
30.11.23Spruce Ridge Resources Ltd. Announces Results of 2023 Annual and Special Meeting of Shareholders178TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Spruce Ridge Resources Ltd., (TSXV: SHL) ("Spruce" or the "Company") is pleased to announce the results of its annual and special meeting of shareholders...
► Artikel lesen
30.11.23RAMM Pharma Corp. Announces Corporate Update244TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- RAMM Pharma Corp. (including its wholly owned subsidiaries, the "Company" or "RAMM") (CSE: RAMM), announces that it has rescinded a grant of 2,000,000 stock...
► Artikel lesen
30.11.23Republic First Bancorp, Inc.: Republic First Bancorp and Norcross Braca Group Provide Update on Closing of $35 Million Capital Investment465PHILADELPHIA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Republic First Bancorp, Inc. (OTCEM: FRBK) ("Republic" or the "Company"), the parent company of Republic First Bank d/b/a Republic Bank, and George...
► Artikel lesen
30.11.23Aptose Biosciences, Inc.: Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role433SAN DIEGO and TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly...
► Artikel lesen
30.11.23Biora Therapeutics, Inc.: Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis205BT-600 will deliver a proprietary liquid formulation of tofacitinib via the NaviCap device for topical delivery to the colon SAN DIEGO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq:...
► Artikel lesen
30.11.23Vision Sensing Acquisition Corp. Announces Intention to Extend Period to Consummate Initial Business Combination to January 3, 2024134MIAMI, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the "Company") a special purpose acquisition company, announced today that it has notified Continental...
► Artikel lesen
30.11.23Rogers Communications, Inc.: Rogers Acquires 3800 MHz 5G Spectrum Across Canada247TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Rogers Communications announced today the company has again secured nationwide 5G spectrum, acquiring 3800 MHz in the country's third 5G spectrum auction...
► Artikel lesen
30.11.23Nayax Ltd.: Nayax Completes Acquisition of Retail Pro International316HERZLIYA, Israel, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX; TASE: NYAX), a global commerce enablement payments and loyalty platform designed to help merchants scale their business...
► Artikel lesen
30.11.23American Environmental Partners, Inc.: American Environmental Partners Announces Third Quarter 2023 Financial Results68Continues Progress on Streamlining Operations to Focus on Core Environmental Services Business CANONSBURG, PA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - American Environmental Partners...
► Artikel lesen
30.11.23ShoulderUp Technology Acquisition Corp. Announces Letter of Intent for a Business Combination122Kennesaw, GA, Nov. 30, 2023 (GLOBE NEWSWIRE) -- ShoulderUp Technology Acquisition Corp. ("ShoulderUp" or the "Company") (NYSE: SUAC.U; SUAC; SUAC.WS) today announced that it has entered into a non-binding...
► Artikel lesen
30.11.23Altimmune, Inc: Altimmune Announces Positive Topline Results from MOMENTUM 48-Week Phase 2 Obesity Trial of Pemvidutide1.920Achieved mean weight loss of 15.6% on 2.4 mg dose of pemvidutide at Week 48, with weight loss continuing at the end of treatmentOver 30% of subjects achieved 20% or more weight loss on 2.4 mg dose...
► Artikel lesen
30.11.23AMN Healthcare Services Inc: AMN Healthcare Completes Acquisition of MSDR305DALLAS, Nov. 30, 2023 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced it has...
► Artikel lesen
30.11.23GigaCloud Technology Inc Announces Third Quarter 2023 Financial Results601Another Consecutive Quarter of Record Profitability Completion of Noble House and Wondersign Acquisitions Subsequent to Quarter End EL MONTE, Calif., Nov. 30, 2023 (GLOBE NEWSWIRE) -- GigaCloud Technology...
► Artikel lesen
Seite:  Weiter >>